Affinage

GNAT1

Guanine nucleotide-binding protein G(t) subunit alpha-1 · UniProt P11488

Length
350 aa
Mass
40.0 kDa
Annotated
2026-06-10
17 papers in source corpus 8 papers cited in narrative 9 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GNAT1 encodes the alpha-subunit of rod transducin, the GTPase that couples photoactivated rhodopsin to the downstream cGMP phosphodiesterase effector in the rod phototransduction cascade (PMID:17584859, PMID:19766629). Distinct disease-causing mutations map onto separable steps of this GTPase cycle: the p.Gly38Asp substitution yields a transducin unable to activate its downstream effector, defining a loss-of-effector-activation mechanism for autosomal dominant CSNB (PMID:17584859), whereas Switch 2 active-site substitutions (p.Gln200Glu, p.Gln200Arg) impair GTPase activity and produce constitutive, light-independent signaling (PMID:17584859, PMID:41954843). Complete loss of the protein, whether by a splice-disrupting nonsense allele in mice or a truncating allele in humans, abolishes rod transducin protein and rod phototransduction and, when fully null, causes progressive rod-cone/retinal degeneration in addition to stationary night blindness (PMID:19766629, PMID:26472407). GNAT1 is expressed predominantly in the retina from early postnatal development (PMID:22190596), and combined loss of rod (Gnat1) and cone (Gnat2) transducin abolishes all rod and cone electroretinographic responses while sparing melanopsin-driven ipRGC cortical responses, demonstrating that GNAT1 is required specifically for the rod arm of image-forming phototransduction (PMID:36605613). CSNB-associated missense variants do not act through protein mislocalization, as their subcellular distribution is unaltered in overexpressing cells (PMID:29850563).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2007 Medium

    Resolved how dominant CSNB mutations corrupt transducin function by separating an effector-activation defect from an active-site GTPase defect, establishing two distinct molecular mechanisms.

    Evidence In vitro effector activation data, trypsin protection assay, and structural modeling of p.G38D and Switch 2 p.Q200E mutants

    PMID:17584859

    Open questions at the time
    • No direct GTPase rate measurement for the Q200E mutant in this work
    • Single lab; effector activation data referenced from prior work
  2. 2009 High

    Showed that disrupting Gnat1 splicing eliminates rod transducin alpha-subunit protein and abolishes rod function, providing an in vivo loss-of-function model.

    Evidence RT-PCR, immunohistochemistry, western blot, and sequencing of IRD1/IRD2 mice carrying a Tyr150Ter nonsense allele

    PMID:19766629

    Open questions at the time
    • Does not address degeneration progression over time
    • Mechanism of dominant human alleles not modeled here
  3. 2012 Medium

    Extended the GNAT1 disease spectrum to autosomal recessive CSNB and defined the retinal, postnatal-onset expression of the gene.

    Evidence Linkage analysis and Sanger sequencing of a consanguineous family plus quantitative ocular expression profiling for the p.D129G allele

    PMID:22190596

    Open questions at the time
    • No in vitro functional reconstitution of the D129G mutant
    • Biochemical consequence of D129G unresolved
  4. 2015 Medium

    Established that complete loss of rod transducin causes progressive retinal degeneration, not merely stationary night blindness, distinguishing null from hypomorphic outcomes.

    Evidence Targeted NGS and clinical characterization of a homozygous truncating allele, corroborated by knockout-mouse comparison

    PMID:26472407

    Open questions at the time
    • Single case
    • Cellular mechanism linking transducin loss to degeneration not defined
  5. 2018 Medium

    Ruled out protein mislocalization as the mechanism for CSNB mutants, including a variant in a predicted NLS and the first alpha-helix distant from the GTP-binding site.

    Evidence Subcellular localization assays in GNAT1-overexpressing mammalian cells plus structural modeling of p.I52N and other mutants

    PMID:29850563

    Open questions at the time
    • Overexpression context may not reflect rod outer segment trafficking
    • Functional consequence of I52N not biochemically measured
  6. 2022 High

    Demonstrated that GNAT1 is required for the rod arm of image-forming vision and that melanopsin ipRGCs can drive cortical responses independently of rod/cone transducin.

    Evidence ERG and VEP recordings in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice

    PMID:36605613

    Open questions at the time
    • Does not dissect rod versus cone contributions to specific behaviors
    • Human relevance of ipRGC-driven cortical signaling untested
  7. 2025 Medium

    Used Gnat1 versus Gnat2 knockout retinas to pharmacologically separate rod and cone PDE6 contributions to downstream RGC signaling.

    Evidence Ex vivo multi-electrode array recordings with Sildenafil PDE6 inhibition in Gnat1 and Gnat2 knockout retinas (preprint)

    PMID:bio_10.1101_2025.10.07.680926

    Open questions at the time
    • Preprint, single lab
    • Addresses cone-pathway pharmacology rather than GNAT1 protein mechanism directly
  8. 2026 Low

    Linked another Switch 2 active-site variant to dominant Riggs-type CSNB via predicted impaired GTPase activity and constitutive signaling.

    Evidence In silico pathogenicity prediction, structural modeling, targeted NGS/Sanger confirmation, and ERG for p.Q200R

    PMID:41954843

    Open questions at the time
    • Mechanistic inference is purely computational without in vitro biochemical validation
    • Single family

Open questions

Synthesis pass · forward-looking unresolved questions
  • How complete loss of rod transducin progresses from stationary dysfunction to photoreceptor degeneration, and the biochemical consequences of recessive missense alleles, remain unresolved.
  • No reconstituted biochemistry for D129G or I52N alleles
  • Mechanism linking null transducin to degeneration uncharacterized
  • Q200R constitutive-activation claim awaits biochemical confirmation

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 3 GO:0003924 GTPase activity 2
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-162582 Signal Transduction 2 R-HSA-9709957 Sensory Perception 2
Partners
PDE6RHO
Complex memberships
rod transducin

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2007 The GNAT1 p.Gly38Asp mutation produces an alpha-transducin that is unable to activate its downstream effector molecule in vitro, establishing a loss-of-effector-activation mechanism for autosomal dominant CSNB. In vitro biochemical assay (effector activation assay referenced as previously published data, cited in context of new mutation analysis) Human mutation Medium 17584859
2007 The GNAT1 p.Gln200Glu substitution in the Switch 2 region (GTPase active site) of alpha-transducin leads to impaired GTPase activity and constitutive activation of phototransduction, as supported by trypsin protection assays and structural modeling based on known crystal structure. Trypsin protection assay; computer modeling based on crystal structure of transducin; in vitro expression of Switch 2 mutants Human mutation Medium 17584859
2009 A nonsense mutation in Gnat1 (Tyr150Ter), caused by a 57-bp intronic deletion disrupting the splice donor site of intron 4, results in absence of rod transducin alpha-subunit (Tralpha) protein and rod dysfunction in IRD1 and IRD2 mice. Quantitative real-time RT-PCR; immunohistochemistry; western blot; cDNA sequencing; genomic sequencing Experimental eye research High 19766629
2012 A homozygous missense mutation p.D129G in GNAT1 segregates with autosomal recessive congenital stationary night blindness in a consanguineous Pakistani family, and Gnat1 is expressed predominantly in the retina starting around postnatal day 7. Genome-wide linkage analysis; Sanger sequencing; quantitative expression analysis in ocular tissues at different postnatal intervals Investigative ophthalmology & visual science Medium 22190596
2015 A homozygous truncating (complete loss-of-function) mutation in GNAT1 causes not only lifelong night blindness but also late-onset retinitis pigmentosa/retinal degeneration, establishing that complete absence of rod transducin alpha-subunit leads to progressive photoreceptor degeneration in addition to stationary dysfunction. Targeted next-generation sequencing of 182 retinopathy-associated genes; clinical characterization including visual field testing and fundus examination The British journal of ophthalmology Medium 26472407
2018 A novel GNAT1 missense variant p.Ile52Asn (c.155T>A) causing adCSNB affects a predicted nuclear localization signal and the first alpha-helix of the protein, distant from the GTP-binding site; subcellular localization of this and other GNAT1 CSNB mutant proteins is unaltered in mammalian overexpressing cells, indicating a mechanism distinct from mislocalization. Domain prediction; 3D structural modeling; subcellular localization assay in mammalian GNAT1-overexpressing cells; co-segregation by sequencing BioMed research international Medium 29850563
2022 Gnat1 knockout mice (lacking rod alpha-transducin) combined with cone alpha-transducin-deficient (Gnat2) mice completely abolish rod and cone photoresponses as confirmed by ERG, yet robust visually evoked potentials persist, demonstrating that melanopsin-expressing ipRGCs can drive primary pattern-forming visual cortex responses independently of rod and cone transducin. Electroretinography (ERG); visually evoked potentials (VEP) in Gnat1-/-; Gnat2cpfl3/cpfl3 double-knockout mice Frontiers in cellular neuroscience High 36605613
2025 Sildenafil (PDE6 inhibitor) completely abolished visually evoked responses in Gnat1-deficient (rod-deficient, cone-only) retinas but not in Gnat2-deficient (cone-deficient, rod-only) retinas ex vivo, demonstrating that Sildenafil preferentially inhibits cone PDE6 and that cone-selective suppression of phototransduction is sufficient to abolish Off-pathway RGC signaling. Ex vivo multi-electrode array recordings from Gnat1 and Gnat2 knockout mouse retinas; pharmacological PDE6 inhibition with Sildenafil; flash and drifting-grating stimuli bioRxivpreprint Medium bio_10.1101_2025.10.07.680926
2026 The GNAT1 p.Gln200Arg variant (c.599A>G) in the Switch 2 GTPase active-site region is predicted by in silico analysis and structural modeling to impair GTPase activity and cause constitutively active signaling after photoactivation, causing autosomal dominant Riggs-type CSNB. In silico pathogenicity prediction tools; protein structural modeling; targeted NGS with Sanger sequencing confirmation; ERG Documenta ophthalmologica. Advances in ophthalmology Low 41954843

Source papers

Stage 0 corpus · 17 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 GNAT1 associated with autosomal recessive congenital stationary night blindness. Investigative ophthalmology & visual science 66 22190596
2016 A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit. Journal of experimental & clinical cancer research : CR 56 27912775
2015 A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration. The British journal of ophthalmology 36 26472407
2007 p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Human mutation 36 17584859
2018 Long non‑coding RNA lnc‑GNAT1‑1 inhibits gastric cancer cell proliferation and invasion through the Wnt/β‑catenin pathway in Helicobacter pylori infection. Molecular medicine reports 21 30132541
2019 Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy. Documenta ophthalmologica. Advances in ophthalmology 18 31583501
2016 Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy. PloS one 18 27977773
2018 Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association. Documenta ophthalmologica. Advances in ophthalmology 13 30051303
2009 A nonsense mutation in Gnat1, encoding the alpha subunit of rod transducin, in spontaneous mouse models of retinal dysfunction. Experimental eye research 12 19766629
2018 A Novel Heterozygous Missense Mutation in GNAT1 Leads to Autosomal Dominant Riggs Type of Congenital Stationary Night Blindness. BioMed research international 11 29850563
2020 Long Non-coding RNA lnc-GNAT1-1 Suppresses Liver Cancer Progression via Modulation of Epithelial-Mesenchymal Transition. Frontiers in genetics 7 33193591
2024 The Plastidial Protein Acetyltransferase GNAT1 Forms a Complex With GNAT2, yet Their Interaction Is Dispensable for State Transitions. Molecular & cellular proteomics : MCP 6 39349166
2007 [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma]. Ai zheng = Aizheng = Chinese journal of cancer 6 17222360
2022 Robust visual cortex evoked potentials (VEP) in Gnat1 and Gnat2 knockout mice. Frontiers in cellular neuroscience 4 36605613
2022 Sleep Deprivation Does not Change the Flash Electroretinogram in Wild-type and Opn4 Mice. Journal of biological rhythms 3 35132885
2019 Novel homozygous in-frame deletion of GNAT1 gene causes golden appearance of fundus and reduced scotopic ERGs similar to that in Oguchi disease in Japanese family. Ophthalmic genetics 2 31696758
2026 Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variant. Documenta ophthalmologica. Advances in ophthalmology 0 41954843

Missed literature

Know a paper Affinage missed for GNAT1? Flag it for the maintainers and the community.

No submissions yet.